Education
About Us
Working with TipRanks
Follow Us
eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 3.55M | $ 1.43M | $ 42.00M | $ 0.00 |
| Gross Profit | $ -111.00K | $ 3.50M | $ 1.41M | $ 42.00M | $ -307.00K |
| Operating Income | $ -33.84M | $ -32.40M | $ -33.33M | $ 15.82M | $ -28.61M |
| EBITDA | $ -32.78M | $ -20.36M | $ 17.59M | $ 16.05M | $ -28.05M |
| Net Income | $ -35.81M | $ -12.93M | $ 15.80M | $ 14.21M | $ -29.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 18.37M | $ 26.31M | $ 49.70M | $ 15.22M | $ 3.43M |
| Total Assets | $ 20.54M | $ 29.08M | $ 54.06M | $ 16.70M | $ 5.09M |
| Total Debt | $ 20.55M | $ 20.28M | $ 20.03M | $ 12.96M | $ 15.24M |
| Net Debt | $ 5.67M | $ 11.57M | $ -29.67M | $ -2.25M | $ 11.82M |
| Total Liabilities | $ 26.34M | $ 25.18M | $ 36.77M | $ 148.95M | $ 18.93M |
| Stockholders' Equity | $ -5.79M | $ 3.90M | $ 17.28M | $ 979.00K | $ -13.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.65M | $ -26.09M | $ -24.93M | $ 13.68M | $ -27.60M |
| Operating Cash Flow | $ -29.55M | $ -25.90M | $ -24.89M | $ 13.84M | $ -27.60M |
| Investing Cash Flow | $ 14.48M | $ -17.86M | $ 565.00K | $ -154.00K | $ 84.00K |
| Financing Cash Flow | $ 21.23M | $ 2.77M | $ 58.81M | $ -1.89M | $ 20.24M |
eFFECTOR Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.